Grassley
Direct
I
spoke
with
Tom
Williamson
of
KIIC
Radio
and
Gordon
Wolf
of
the
Denison
Bulletin
Review
about
the
President-elect’s
nominee
for
the
Office
of
Management
and
Budget,
agriculture
policy
under
the
new
administration,
limitations
and
changes
to
midnight
regulations,
and
the
repeal
and
replacement
of
Obamacare.
Q&A:
Restoring
Checks
and
Balances
Q.
What
is
the
REINS
Act?
Q.
What
other
ways
are
you
working
to
advance
common
sense
regulatory
relief?
Quick
Links
I
met
with
Rep.
Mick
Mulvaney,
President-elect
Trump's
nominee
to
be
Director
of
the
Office
of
Management
and
Budget
(OMB).
OMB
has
a
tremendous
amount
of
power
over
cost
savings
and
other
oversight
practices
throughout
the
executive
branch.
Rep.
Mulvaney
listened
carefully
to
my
suggestions
on
specific
management
and
oversight
issues.
I
look
forward
to
the
rest
of
his
confirmation
process.
I
also
had
a
chance
to
meet
with
the
President-elect's
nominee
to
be
Secretary
of
Homeland
Security,
Gen.
John
Kelly. It
was
clear
to
me
from
our
conversation
that
Gen.
Kelly
understands
the
critical
importance
of
border
security
and immigration
enforcement
to
the
overall
security
of
our
country.
I
presided
over
the
Senate
Judiciary
Committee's
two-day hearing
on
the
nomination
of Senator
Jeff
Sessions
to
be
United
States
Attorney
General. Over
the
course
of
those
two
days,
Senator
Sessions
and
other
witnesses
provided
testimony
that
affirmed
his
decades-long
dedication
to
public
service
and
commitment
to
faithful
and
fair
execution
of
the
law. You
can
watch
my
opening
remarks
from
the
hearings
here.
I
worked
with
two
of
my
colleagues
to
re-introduce
a
bipartisan
bill
that
would
help
pharmacists
provide
medical
care
to
older
Americans
in
communities
lacking
easy
access
to
doctors.
A
lot
of
people
in
rural
Iowa
have
easier
access
to
a
pharmacist
than
a
doctor,
and
Medicare
ought
to
pay
when
those
pharmacists
provide
medical
services.
This
bill
works
for
rural
seniors
because
they
keep
access
to
their
local
pharmacist
and
don't
have
to
go
to
the
doctor
for
straightforward
medication
management.
I
also
introduced
a
bill
this
week
to
address
the
high
cost
of
prescription
drugs.
The
bill,
called
'Preserve
Access
to
Affordable
Generics
Act,'
would
crack
down
on
an
anti-competitive
tactic
called
pay-for-delay
where
brand-name
drug
companies
pay
generic
drug
makers
to
keep
less
costly
medications
off
the
market.
This
practice
raises
the
cost
of
prescriptions,
leaving
all
of
us
to
pay
the
price.
Post
of
the
Week
|